Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-06-20
2008-09-16
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S236100, C424S009100, C514S002600, C514S012200, C530S350000, C435S252700
Reexamination Certificate
active
07425338
ABSTRACT:
Agents for treating pain, methods for producing the agents and methods for treating pain by administration to a patient of a therapeutically effective amount of the agent. The agent can include a clostridial neurotoxin, or a component or fragment or derivative thereof, attached to a targeting moiety, wherein the targeting moiety is selected from a group consisting of transmission compounds which can be released from neurons upon the transmission of pain signals by the neurons, and compounds substantially similar to the transmission compounds.
REFERENCES:
patent: 4189426 (1980-02-01), Li
patent: 4481139 (1984-11-01), Folkers et al.
patent: 4664911 (1987-05-01), Uhr et al.
patent: 4719231 (1988-01-01), Umezawa et al.
patent: 5410019 (1995-04-01), Coy et al.
patent: 5714468 (1998-02-01), Binder
patent: 5744131 (1998-04-01), Edwards et al.
patent: 5766605 (1998-06-01), Sanders et al.
patent: 5846216 (1998-12-01), Gonzales et al.
patent: 5861284 (1999-01-01), Nishimura et al.
patent: 5891842 (1999-04-01), Kream
patent: 5965406 (1999-10-01), Murphy
patent: 5989545 (1999-11-01), Foster et al.
patent: 6632440 (2003-10-01), Quinn et al.
patent: 7056729 (2006-06-01), Donovan
patent: 7138127 (2006-11-01), Donovan
patent: 9532738 (1995-07-01), None
patent: 9633273 (1996-10-01), None
patent: 9801754 (1998-01-01), None
patent: 9807864 (1998-08-01), None
patent: 9917806 (1999-04-01), None
XP-00857076, Mosaic Structres of Neurotoxins Produced from Clostridium botulinum types C and D organisms, Morishi et al, Biochimca et Biophysica Acta, 1307 (1996) 123-126.
XP001011356, Berge, O-G et al, Selective Neurotoxic Lesions of Descending Serotonergic and Noadrenergic Pathways in the Rat, Journal of Neurochemistry; 44(4):1156-1161(1985).
XP001012206, Benoliel, R et al, Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain, Pain; 79(2-3):243-253(1999).
XP001011386, Garzon, J et al, Effect of intrathecal injection of pertusis toxin on substance P norepinephrine and serotonin contents in various neural structures of arthritic rats; Life Sciences; 47(21);1915-1924(1990).
Bernardi, “Synthetic Peptides Related to Eledoisin”, Experientia 21(12); 695-7, 1965.
Bernardi, “Synthetic Peptides Related to Eledoisin Physalaemin-Like Peptides”, Experientia 22(1); 29-31, 1966.
Bernardi, “Synthetic Peptides Related to Eledoisin”, Experientia 20(6); 306-309, 1964.
deCaro et al, “Effect of Eledoisin, Physalaemin and Some Eledoisin-or Physalaemin-Like Peptides on Water Intake and Arterial Blood Pressure in Conscious Pigeons”, Pharmacol Research Comm., vol. 11, No. 10, 891-901, 1979.
Helke et al, “Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms”, FASEB, 1606-1615, 1990.
Labrou et al, “Structure-activity studies on cysteine-substituted neurokinin A analogs”, Peptides 20, 795-801, 1999.
Regoli et al, Neurokinin Receptor Substypes Characterized by Biological Assays, Life Sciences, vol. 54, 26, 2035-2047, 1994.
Regoli et al, “Receptors and Antagonists for Substance P and Related Peptides”, Pharmacol Rev., vol. 46, No. 4, 551-599, 1994.
Shroeder, “D-Aminosaurehaltige Analoga des Eledoisins”, Experientia, 21, 70-71, 1965.
Simmaco et al, “Six Novel Tachykinin- and Bombesin-Related Peptides From Skin of the Australian Frog Pseudophryne guntheri” Peptides, vol. 11, 299-304, 1990.
Fregnan et al, “Further Studies of the Action on Smooth Muscle of Eledoisin-Fragments and Eledoisin-Like Hepta- and Hexapeptides”, Euro Journ, 4, 421-426, 1968.
Allergan Inc.
German Joel B.
Kam Chih-Min
Stathakis Dean G.
Voet Martin A.
LandOfFree
Clostridial toxin derivatives and methods for treating pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clostridial toxin derivatives and methods for treating pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clostridial toxin derivatives and methods for treating pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3992479